Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb (or BMS), joins a16z Bio + Health general partner Jorge Conde.
Together, they talk about how AI could transform drug discovery and development at a large biopharma company—and how a company might have to adapt to harness AI; modalities they’re excited about; and Greg’s do’s and don’ts for startups looking to partner with a company like BMS.
Drag & Drop Genome Editing
Past, Present, and Future of AI with Vijay Pande
Fireside Chat with Sean Duffy
Introducing: Raising Health
Generalist Medical AI with Pranav Rajpurkar
Gate Unveiling with Jordi Mata-Fink
How to Build an AI-Native Health Plan with Mario Schlosser
Bridging AI, Ethics, and Consumer Trust with Miriam Vogel
Clinical Copilots: Augmenting Human Care with Suchi Saria
The Worlds She Sees with Fei-Fei Li
Supercharging Discovery with Evan Feinberg
Evolving Biotechnologies with Olga Troyanskaya
CMO vs. CPO with Peter Shalek and Reena Pande
Interpretability and the AI "Clear Box" with Surya Ganguli
AI Revolution with Daphne Koller
When Quantity Becomes Quality with Aviv Regev
Navigating the Future of AI with Andrew Ng
Unleashing CAR T with Carl June
Becoming a Partnership Pioneer with Dan Nomura
Wartime and Peacetime: Being a Leader with Ben Horowitz
Create your
podcast in
minutes
It is Free